Dr. Guido Rubboli – What do we know of the experience with cenobamate in Nordic countries? Real‑world results from The Danish Epilepsy Centre, Dianalund, Denmark

Dr. Guido Rubboli talks about first Nordic real-world evidence study of cenobamate use

Real-world evidence from the Nordics

Professor Guido Rubboli discusses the findings of a recent study conducted at The Danish Epilepsy Centre, shedding light on the potential of cenobamate as an add-on treatment for ultra-refractory focal epilepsy. The study underscores the long-term efficacy and tolerability of this medication, highlighting its role in addressing a critical unmet need within the epilepsy community. Watch this short video to know more of the study’s key contributions and its broader impact.

Professor Guido Rubboli is Director of the Adult Department at the Danish Epilepsy Center in Dianalund and Clinical professor of clinical epileptology, Institute of Clinical Medicine, University of Copenhagen. Currently, his main fields of research are clinical management and clinical neurophysiology, including presurgical evaluation, of difficult-to-treat epilepsies, genetics of rare and complex epilepsies, targeted treatments in genetic epilepsies and developmental epileptic encephalopathies.

Ontozry produktinformasjon

MAT-DK-0065-P 6.11.2025